NO20023468D0 - Vannlöselige prodrugs av azol-forbindelser - Google Patents
Vannlöselige prodrugs av azol-forbindelserInfo
- Publication number
- NO20023468D0 NO20023468D0 NO20023468A NO20023468A NO20023468D0 NO 20023468 D0 NO20023468 D0 NO 20023468D0 NO 20023468 A NO20023468 A NO 20023468A NO 20023468 A NO20023468 A NO 20023468A NO 20023468 D0 NO20023468 D0 NO 20023468D0
- Authority
- NO
- Norway
- Prior art keywords
- water
- azole compounds
- soluble prodrugs
- soluble
- triazole antifungal
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 150000003851 azoles Chemical class 0.000 title 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 3
- 229940121375 antifungal agent Drugs 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 150000003852 triazoles Chemical class 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
- C07F9/6518—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polymerization Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17716900P | 2000-01-20 | 2000-01-20 | |
US24996900P | 2000-11-20 | 2000-11-20 | |
PCT/US2001/001284 WO2001052852A1 (en) | 2000-01-20 | 2001-01-16 | Water soluble prodrugs of azole compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20023468D0 true NO20023468D0 (no) | 2002-07-19 |
NO20023468L NO20023468L (no) | 2002-07-29 |
NO330352B1 NO330352B1 (no) | 2011-04-04 |
Family
ID=26873001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20023468A NO330352B1 (no) | 2000-01-20 | 2002-07-19 | Vannloselige prodrugs av azol-forbindelser, farmasoytiske blandinger omfattende slike, fremgangsmate for fremstilling av slike samt slike forbindelser for behandling av sykdom. |
Country Status (22)
Country | Link |
---|---|
US (1) | US6362172B2 (no) |
EP (1) | EP1284737B1 (no) |
JP (1) | JP3766804B2 (no) |
KR (1) | KR100748299B1 (no) |
CN (1) | CN1178665C (no) |
AT (1) | ATE300946T1 (no) |
AU (1) | AU782177C (no) |
BR (1) | BR0107618A (no) |
CA (1) | CA2397734C (no) |
CZ (1) | CZ20022822A3 (no) |
DE (1) | DE60112433T2 (no) |
DK (1) | DK1284737T5 (no) |
ES (1) | ES2247131T3 (no) |
HU (1) | HU229226B1 (no) |
IL (2) | IL150798A0 (no) |
MX (1) | MXPA02007120A (no) |
NO (1) | NO330352B1 (no) |
NZ (1) | NZ519354A (no) |
PL (1) | PL206024B1 (no) |
PT (1) | PT1284737E (no) |
RU (1) | RU2266909C2 (no) |
WO (1) | WO2001052852A1 (no) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6448401B1 (en) * | 2000-11-20 | 2002-09-10 | Bristol-Myers Squibb Company | Process for water soluble azole compounds |
HUP0303249A3 (en) | 2001-02-22 | 2007-03-28 | Sankyo Co | Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
EP1534286B1 (en) | 2002-07-29 | 2009-12-09 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
DE602006010979D1 (de) | 2005-01-19 | 2010-01-21 | Rigel Pharmaceuticals Inc | Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen |
JO2691B1 (en) * | 2005-05-03 | 2013-03-03 | ايساي آر آند دي مانجمنت كو.، ليمتد | Monolysine salts for azole compounds |
DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
JP5046959B2 (ja) * | 2005-12-20 | 2012-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 水溶性アゾールプロドラッグの製造方法 |
WO2007092580A2 (en) * | 2006-02-08 | 2007-08-16 | Phibro-Tech Inc. | Biocidal azole emulsion concentrates having high active ingredient content |
CN101890028A (zh) * | 2006-02-22 | 2010-11-24 | 卫材R&D管理有限公司 | 稳定化药物组合物 |
NO347644B1 (no) | 2006-05-04 | 2024-02-12 | Boehringer Ingelheim Int | Polymorfer |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
AR071175A1 (es) | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
WO2009143297A1 (en) | 2008-05-20 | 2009-11-26 | Neurogesx, Inc. | Carbonate prodrugs and methods of using the same |
JP5757864B2 (ja) | 2008-05-20 | 2015-08-05 | ニューロジェシックス, インコーポレイテッド | 水溶性アセトアミノフェン類似体 |
KR20200118243A (ko) | 2008-08-06 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
US8513264B2 (en) | 2008-09-10 | 2013-08-20 | Boehringer Ingelheim International Gmbh | Combination therapy for the treatment of diabetes and related conditions |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
MX2011006713A (es) | 2008-12-23 | 2011-07-13 | Boehringer Ingelheim Int | Formas salinas de compuesto organico. |
TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
EA034869B1 (ru) | 2009-11-27 | 2020-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин |
MX341025B (es) | 2010-05-05 | 2016-08-04 | Boehringer Ingelheim Int Gmbh * | Terapia de combinacion. |
BR112012032579B1 (pt) | 2010-06-24 | 2021-05-11 | Boehringer Ingelheim International Gmbh | uso de linagliptina e composição farmacêutica compreendendo linagliptina e insulina basal de longa duração |
US20130288956A1 (en) | 2010-11-05 | 2013-10-31 | Eisai R&D Management Co., Ltd. | Combined pharmaceutical composition as antifungal agent |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
WO2012083138A2 (en) * | 2010-12-16 | 2012-06-21 | Board Of Regents, The University Of Texas System | Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds |
CN103857440B (zh) | 2011-06-22 | 2018-09-25 | 维奥姆生物科学有限公司 | 基于缀合物的抗真菌和抗细菌前药 |
KR101985384B1 (ko) | 2011-07-15 | 2019-06-03 | 베링거 인겔하임 인터내셔날 게엠베하 | 치환된 퀴나졸린, 이의 제조 및 약제학적 조성물에서의 이의 용도 |
US8426450B1 (en) * | 2011-11-29 | 2013-04-23 | Helsinn Healthcare Sa | Substituted 4-phenyl pyridines having anti-emetic effect |
KR102061137B1 (ko) * | 2012-01-20 | 2019-12-31 | 마이코비아 파마슈티컬즈, 인코포레이티드 | 금속효소 억제제 화합물 |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
AU2013250251B2 (en) * | 2012-04-20 | 2017-05-11 | Eisai R&D Management Co., Ltd. | Encapsulated formulation |
WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
EA201592236A1 (ru) | 2013-06-04 | 2016-06-30 | Вайом Байосайнсиз Пвт. Лтд. | Частицы с нанесенным покрытием и композиции, включающие такие частицы |
MX2016009898A (es) | 2014-01-29 | 2017-01-23 | Vyome Biosciences Pvt Ltd | Tratamientos para acne resistente. |
US9526728B2 (en) | 2014-02-28 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Medical use of a DPP-4 inhibitor |
CN104926870B (zh) * | 2014-03-21 | 2017-02-08 | 合肥久诺医药科技有限公司 | 一种福司氟康唑的精制方法 |
US9725473B2 (en) * | 2015-07-28 | 2017-08-08 | Beta Cat Pharmaceuticals, Inc. | Anthracene-9, 10-dione dioxime compound prodrugs and their uses |
CN109310697A (zh) | 2016-06-10 | 2019-02-05 | 勃林格殷格翰国际有限公司 | 利格列汀和二甲双胍的组合 |
CN107501255B (zh) * | 2017-09-12 | 2019-08-23 | 成都施贝康生物医药科技有限公司 | 一种艾沙康唑衍生物及其用途 |
CN108676031A (zh) * | 2018-05-29 | 2018-10-19 | 重庆威鹏药业有限公司 | 水溶性三唑类抗真菌膦酸化合物及其制备方法和应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9308012A (es) | 1992-12-24 | 1994-08-31 | Bristol Myers Squibb Co | Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen. |
CA2129288C (en) | 1993-08-17 | 2000-05-16 | Jerzy Golik | Phosphonooxymethyl esters of taxane derivatives |
US5714490A (en) * | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
PT736030E (pt) | 1993-12-21 | 2002-01-30 | Schering Corp | Antifungicos de tetra-hidrofurano |
SI0741737T1 (en) | 1994-01-24 | 2000-02-29 | Janssen Pharmaceutica N.V. | Watersoluble azole antifungals |
NZ270418A (en) | 1994-02-07 | 1997-09-22 | Eisai Co Ltd | Polycyclic triazole & imidazole derivatives, antifungal compositions |
HUP9701690A3 (en) | 1995-06-02 | 1998-04-28 | Schering Corp Kenilwort | Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same |
TW354293B (en) * | 1995-06-06 | 1999-03-11 | Bristol Myers Squibb Co | Prodrugs of paclitaxel derivatives |
GB9602080D0 (en) | 1996-02-02 | 1996-04-03 | Pfizer Ltd | Pharmaceutical compounds |
EP0829478A3 (en) | 1996-09-09 | 1998-03-25 | F. Hoffmann-La Roche Ag | N-Benzylimidazolium and N-benzyltriazolium derivatives, their preparation and their use as antifungal and antimycotic agents |
ES2209394T3 (es) | 1998-01-29 | 2004-06-16 | Bristol-Myers Squibb Company | Derivados fosfato de diaril 1,3,4-oxadiazolona. |
US5883097A (en) | 1998-04-16 | 1999-03-16 | Schering Corporation | Soluble azole antifungal salt |
US6204257B1 (en) * | 1998-08-07 | 2001-03-20 | Universtiy Of Kansas | Water soluble prodrugs of hindered alcohols |
AU1915500A (en) * | 1998-11-20 | 2000-06-13 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
US6448401B1 (en) * | 2000-11-20 | 2002-09-10 | Bristol-Myers Squibb Company | Process for water soluble azole compounds |
-
2001
- 2001-01-10 US US09/757,438 patent/US6362172B2/en not_active Expired - Lifetime
- 2001-01-16 EP EP01942553A patent/EP1284737B1/en not_active Expired - Lifetime
- 2001-01-16 BR BR0107618-3A patent/BR0107618A/pt active Search and Examination
- 2001-01-16 KR KR1020027009320A patent/KR100748299B1/ko active IP Right Grant
- 2001-01-16 DE DE60112433T patent/DE60112433T2/de not_active Expired - Lifetime
- 2001-01-16 CA CA2397734A patent/CA2397734C/en not_active Expired - Lifetime
- 2001-01-16 WO PCT/US2001/001284 patent/WO2001052852A1/en active IP Right Grant
- 2001-01-16 CN CNB018038581A patent/CN1178665C/zh not_active Expired - Lifetime
- 2001-01-16 MX MXPA02007120A patent/MXPA02007120A/es active IP Right Grant
- 2001-01-16 PL PL356164A patent/PL206024B1/pl not_active IP Right Cessation
- 2001-01-16 CZ CZ20022822A patent/CZ20022822A3/cs unknown
- 2001-01-16 AU AU29485/01A patent/AU782177C/en not_active Expired
- 2001-01-16 IL IL15079801A patent/IL150798A0/xx active IP Right Grant
- 2001-01-16 ES ES01942553T patent/ES2247131T3/es not_active Expired - Lifetime
- 2001-01-16 HU HU0204405A patent/HU229226B1/hu not_active IP Right Cessation
- 2001-01-16 JP JP2001552899A patent/JP3766804B2/ja not_active Expired - Lifetime
- 2001-01-16 DK DK01942553T patent/DK1284737T5/da active
- 2001-01-16 PT PT01942553T patent/PT1284737E/pt unknown
- 2001-01-16 RU RU2002118606/04A patent/RU2266909C2/ru active
- 2001-01-16 NZ NZ519354A patent/NZ519354A/en not_active IP Right Cessation
- 2001-01-16 AT AT01942553T patent/ATE300946T1/de active
-
2002
- 2002-07-17 IL IL150798A patent/IL150798A/en unknown
- 2002-07-19 NO NO20023468A patent/NO330352B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20023468D0 (no) | Vannlöselige prodrugs av azol-forbindelser | |
AU2001239725A1 (en) | Antibacterial agents | |
AU7278500A (en) | Fungicides | |
MXPA03004696A (es) | COMPOSICIONES FOTOCROMICAS ORGANICAS DE DESEMPEnO CINETICO MEJORADO. | |
AU2002219718A1 (en) | Process for oxidising primary alcohols | |
MXPA03002857A (es) | Hidroxiesteres de 7-desmetil-rapamicina. | |
AU2001283989A1 (en) | Surface-active photoinitiators | |
SE0004245D0 (sv) | Novel compounds and their use | |
NO20032241D0 (no) | Forbedret prosess for vannlöselige azolforbindelser | |
AU2002231669A1 (en) | Surface-active photoinitiators | |
AU2002213459A1 (en) | Phosphorus-silicate fibers suitable for extended band amplification | |
AU2002220244A1 (en) | Azole containing compositions with enhanced antifungal activity | |
AU2002211050A1 (en) | Streptomyces kasugaensis inhibiting the fungal pathogens of plant | |
AUPQ629000A0 (en) | Inhibition of fungi | |
WO2002048143A3 (en) | Antimicrobial 2-pyridones, their compositions and uses | |
AU6900001A (en) | Improving the performance of a cdma system | |
AU2001226604A1 (en) | Fluted static stack agitator | |
MY125989A (en) | Water soluble prodrugs of azole compounds | |
AU2002239680A1 (en) | Aggrecanase adamts9 | |
AU2001284891A1 (en) | Micronized leflunomide | |
AU2002217792A1 (en) | Writable document protector assembly | |
AU2000236832A1 (en) | Double axled rotationturbine | |
AU2001282779A1 (en) | Ventilated work chamber arrangement | |
AU2002210437A1 (en) | Organizer | |
AUPQ955900A0 (en) | DMS:acceptor oxidoreductase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |